{"name":"Everfront Biotech Co., Ltd.","slug":"everfront-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cerebraca wafer","genericName":"Cerebraca wafer","slug":"cerebraca-wafer","indication":"Other","status":"phase_2"},{"name":"EF-009","genericName":"EF-009","slug":"ef-009","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Cerebraca wafer","genericName":"Cerebraca wafer","slug":"cerebraca-wafer","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EF-009","genericName":"EF-009","slug":"ef-009","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNaWEwa0FZU29NSnZ6X18wZmpka29ldXBDVkR3dGV4Z1hveHI5TjZaUm43WDNmRmtMS2xkcXJzRzRpZUV2SFFMZ0ZLTndZOGNRUzJTQ09oU3dPV2NCTjA3RjZ2VHQxMlJGS2M0TkhuWFgySm90bktPcmpsUGtMRG1KU3ctOGhSVmpIQ3ZQeGw3TFlPRWtURWhCYnJMdw?oc=5","date":"2026-04-08","type":"trial","source":"openPR.com","summary":"High-Grade Glioma Clinical Trial and Pipeline Analysis 2026: - openPR.com","headline":"High-Grade Glioma Clinical Trial and Pipeline Analysis 2026:","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}